FDA Investigator: Paul C. Mouris
- Paul C. Mouris first started conducting FDA inspections in 2004, with the last inspection in 2023. Over that time, Paul C. Mouris has conducted 123 inspections at 81 companies across 86 sites.
Get Paul Mouris's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 IV Solutions of Lubbock, Lubbock | March 2013
Available Now - $199
Paul C. Mouris
Animal Drugs & Feed Form 483
FDA 483 Central Admixture Pharmacy Services, Homewood | 2013
Available Now - $199
Paul C. Mouris
Human Drug Form 483
FDA 483 Greenbrier International, Inc, Chesapeake | 2019
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Cipla Limited, Pithampur, District Dhar | 2018
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Silarx Pharmaceutical, Inc., Carmel | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Fougera Pharmaceuticals, Inc., Melville | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Ultra Seal Corporation, New Paltz | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Corden Pharma Latina S.p.A., Sermoneta | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Corden Pharma Latina S.p.A., Sermoneta | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Pfizer Inc, Rouses Point | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals), Pomona | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Regeneron Pharmaceuticals Inc, Tarrytown | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Velocity Pharma LLC, Farmingdale | 2013
Out-of-stock
Paul C. Mouris
Human Drug Form 483
FDA 483 Novartis Pharmaceuticals Corp., Suffern | 2012
Out-of-stock
Paul C. Mouris
Human Drug Form 483
Co-Investigators (44)
- Juanita P. Versace, FDA Investigator
- Anastasia M. Shields, FDA Investigator
- Sony Mathews, FDA Investigator
- Nancy F. Scheraga, FDA Investigator
- Abby L. Mozeke-Baker, FDA Investigator
- Patric C. Klotzbuecher, FDA Investigator
- Scott T. Ballard, FDA Investigator
- Marie A. Fadden, FDA Investigator
- Michael E. Maselli, FDA Investigator
- Philip F. Istafanos, FDA Investigator
- Kenneth H. Williams, FDA Investigator
- Charisse K. Green, FDA Investigator
- Valentino Fiorella, FDA Investigator
- Kazi Rafiquzzaman, FDA Investigator
- Kenneth G. Klobus, FDA Investigator
- Addam S. Reynolds, FDA Investigator
- Karen L. Kosar, FDA Investigator
- Neil J. Bonzagni, FDA Investigator
- Alice S. Tsao, FDA Investigator
- James D. Bridges, FDA Investigator
- Frank Verni, FDA Investigator
- Steven M. Weinman, FDA Investigator
- Robert C. Steyert, FDA Investigator
- Gary J. Lehr, FDA Investigator
- Xiaokuang Lai, FDA Investigator
- Kwong P. Lee, FDA Investigator
- Anna M. Alexander, FDA Investigator
- Uduak M. Inokon, FDA Investigator
- Huascar Batista, FDA Investigator
- Marianna Viner, FDA Investigator
- Kevin A. Gonzalez, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Michael R. Dominick, FDA Investigator
- Felix Maldonado, FDA Investigator
- Demitria J. Xiradakis, FDA Investigator
- Samuel T. Walker, FDA Investigator
- Matthew A. Spataro, FDA Investigator
- Paul E. Stein, FDA Investigator
- Evelyn Taha, FDA Investigator
- Alia Legaux, FDA Investigator
- Amy W. Yan Mai, FDA Investigator
- L G. Massimilla, FDA Investigator
- Lisa Mathew, FDA Investigator
- Yan Mai, Amy W, FDA Investigator